PFM Health Sciences, LP
CIK: 0001442756Latest portfolio: $1.0B · Q4 2025
Holdings
77
Total Value
$1.0B
New Positions
30
Closed Positions
23
Top Holdings
View All 77 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | THCTENET HEALTHCARE CORP | 397,767 | $79.0M | 7.88% | -63,887 | |
| 2 | LLYELI LILLY & CO | 68,289 | $73.4M | 7.32% | -156,850 | |
| 3 | AXSMAXSOME THERAPEUTICS INC | 251,562 | $45.9M | 4.58% | -278,770 | |
| 4 | CNCCENTENE CORP DEL | 1,097,724 | $45.2M | 4.50% | NEW | Call |
| 5 | PENPENUMBRA INC | 145,171 | $45.1M | 4.50% | -49,914 | |
| 6 | ASNDASCENDIS PHARMA A/S | 177,685 | $37.9M | 3.78% | +32K | |
| 7 | UTHUNITED THERAPEUTICS CORP DEL | 67,743 | $33.0M | 3.29% | -27,907 | |
| 8 | BBIOBRIDGEBIO PHARMA INC | 306,506 | $23.4M | 2.34% | -20,668 | |
| 9 | ADMAADMA BIOLOGICS INC | 1,270,894 | $23.2M | 2.31% | +90K | |
| 10 | NBIXNEUROCRINE BIOSCIENCES INC | 163,197 | $23.1M | 2.31% | +106K | |
| 11 | GKOSGLAUKOS CORP | 201,676 | $22.8M | 2.27% | NEW | |
| 12 | TMOTHERMO FISHER SCIENTIFIC INC | 37,915 | $22.0M | 2.19% | +36K | |
| 13 | EWEDWARDS LIFESCIENCES CORP | 246,835 | $21.0M | 2.10% | -134,489 | |
| 14 | ICLRICON PLC | 115,336 | $21.0M | 2.10% | -18,347 | |
| 15 | INBXINHIBRX BIOSCIENCES INC | 265,517 | $21.0M | 2.09% | +26K | |
| 16 | MDTMEDTRONIC PLC | 213,796 | $20.5M | 2.05% | NEW | |
| 17 | NEONEOGENOMICS INC | 1,694,051 | $19.9M | 1.99% | -514,479 | |
| 18 | MRKMERCK & CO INC | 187,834 | $19.8M | 1.97% | -48,634 | |
| 19 | AMRXAMNEAL PHARMACEUTICALS INC | 1,465,480 | $18.5M | 1.84% | +1.1M | |
| 20 | SYKSTRYKER CORPORATION | 50,852 | $17.9M | 1.78% | NEW | |
| 21 | UNHUNITEDHEALTH GROUP INC | 50,539 | $16.7M | 1.66% | NEW | |
| 22 | WATWATERS CORP | 43,208 | $16.4M | 1.64% | +12K | |
| 23 | ASND 2.25 04/01/28ASCENDIS PHARMA A/S | 10,655,000 | $15.1M | 1.51% | -860,000 | |
| 24 | DC4DEXCOM INC | 227,357 | $15.1M | 1.50% | NEW | |
| 25 | CNTACENTESSA PHARMACEUTICALS PLC | 591,601 | $14.8M | 1.48% | -74,595 |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
Healthcare0.0% ($7.904473388459455e+295T)
Unknown0.0% ($3300715134150891520.0T)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $1.0B | 78 |
| Q3 2025 | Nov 14, 2025 | $1.3T | 72 |
| Q2 2025 | Aug 14, 2025 | $1.2T | 57 |
| Q1 2025 | May 15, 2025 | $1.4T | 66 |
| Q4 2024 | Feb 14, 2025 | $1.6T | 83 |
| Q3 2024 | Nov 14, 2024 | $1764.8T | 75 |
| Q2 2024 | Aug 14, 2024 | $2020.8T | 78 |
| Q1 2024 | May 14, 2024 | $2127.3T | 87 |
| Q4 2023 | Feb 14, 2024 | $1667.2T | 65 |
| Q3 2023 | Nov 14, 2023 | $2122.8T | 73 |
| Q2 2023 | Aug 14, 2023 | $2575.6T | 83 |
| Q1 2023 | May 15, 2023 | $2264.1T | 78 |
| Q4 2022 | Feb 14, 2023 | $2792.8T | 89 |
| Q3 2022 | Nov 14, 2022 | $2.8T | 85 |
| Q2 2022 | Aug 15, 2022 | $2.6T | 80 |
| Q1 2022 | May 16, 2022 | $2.7T | 68 |
| Q4 2021 | Feb 14, 2022 | $2.9T | 71 |
| Q3 2021 | Nov 15, 2021 | $3.4T | 85 |
| Q2 2021 | Aug 16, 2021 | $3.2T | 84 |
| Q1 2021 | May 17, 2021 | $3.3T | 86 |
| Q4 2020 | Feb 16, 2021 | $2.7T | 85 |
| Q3 2020 | Nov 16, 2020 | $2.2T | 77 |
| Q2 2020 | Aug 14, 2020 | $1.9T | 76 |
| Q1 2020 | May 15, 2020 | $1.2T | 61 |
| Q4 2019 | Feb 14, 2020 | $2.1T | 61 |
| Q3 2019 | Nov 14, 2019 | $3.4T | 72 |
| Q2 2019 | Aug 14, 2019 | $5.3T | 85 |
| Q1 2019 | May 15, 2019 | $4.5T | 90 |
| Q4 2018 | Feb 14, 2019 | $3.8T | 94 |
| Q3 2018 | Nov 13, 2018 | $6.8T | 117 |
| Q2 2018 | Aug 14, 2018 | $6.4T | 122 |
| Q1 2018 | May 15, 2018 | $4.9T | 94 |
| Q4 2017 | Feb 14, 2018 | $4.2T | 81 |
| Q3 2017 | Nov 14, 2017 | $5.1T | 89 |
| Q2 2017 | Aug 14, 2017 | $3.7T | 90 |
| Q1 2017 | May 15, 2017 | $4.0T | 99 |
| Q4 2016 | Feb 14, 2017 | $3.5T | 93 |
| Q3 2016 | Nov 14, 2016 | $3.4T | 85 |
| Q2 2016 | Aug 15, 2016 | $3.3T | 81 |
| Q1 2016 | May 16, 2016 | $3.2T | 82 |
Fund Information
PFM Health Sciences, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.0B across 77 holdings. The largest position is TENET HEALTHCARE CORP (THC), representing 7.9% of the portfolio. Compared to the previous quarter, the fund opened 31 new positions and closed 24 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.